MLYS: Mineralys Therapeutics, Inc. Stock

by  •  • Comments Off on MLYS: Mineralys Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 474.93
Enterprise Value ($M) 360.84
Book Value ($M) 191.26
Book Value / Share 3.84
Price / Book 2.48
NCAV ($M) 190.71
NCAV / Share 3.83
Price / NCAV 2.49

Profitability (mra)
Return on Invested Capital (ROIC) -0.93
Return on Assets (ROA) -0.71
Return on Equity (ROE) -0.74

Liquidity (mrq)
Quick Ratio 14.02
Current Ratio 14.02

Balance Sheet (mrq) ($M)
Current Assets 205.35
Assets 205.90
Liabilities 14.65
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -192.40
Net Income -177.81

Cash Flow Statement (mra) ($M)
Cash From Operations -166.31
Cash from Investing 114.96
Cash from Financing 116.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G/A Adams Street Partners Llc
11-13 13G/A Catalys Pacific Fund, LP 17.40 -5.73
11-13 13G/A HBM Healthcare Investments (Cayman) Ltd. 4.50 0.00
11-13 13G/A TCG Crossover GP II, LLC 5.00 -22.45
2024-02-12 13D/A Samsara BioCapital, L.P. 10.30 12.61
2024-02-12 13D/A Ra Capital Management, L.p. 9.99 55.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 62,834 302,300 20.79
2025-02-20 63,321 280,773 22.55
2025-02-19 108,079 388,999 27.78
2025-02-18 119,496 554,589 21.55

(click for more detail)

Similar Companies
MGNX – MacroGenics, Inc. MGTX – MeiraGTx Holdings plc
MIST – Milestone Pharmaceuticals Inc. MNMD – Mind Medicine (MindMed) Inc.
MRNA – Moderna, Inc.


Financial data and stock pages provided by
Fintel.io